MIRA Pharmaceuticals (MIRA) Institutional Ownership $1.06 +0.06 (+6.00%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for MIRA Pharmaceuticals (NASDAQ:MIRA)CurrentInstitutional OwnershipPercentage35.16%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$614.23KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$22.75K Get MIRA Insider Trade Alerts Want to know when executives and insiders are buying or selling MIRA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MIRA Institutional Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover MIRA Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/23/2024 Cross Staff Investments Inc365,901$476K0.4%-4.6%2.475% 10/21/2024 Suncoast Equity Management90,000$117K0.0%+125.0%0.609% 5/20/2024 Virtu Financial LLC63,055$69K0.0%+330.2%0.427% 5/2/2024 Suncoast Equity Management40,000$44K0.0%N/A0.271% 5/2/2024 Cross Staff Investments Inc383,401$422K0.4%N/A2.594% 4/10/2024 Praetorian Wealth Management Inc.27,500$30K0.0%N/A0.186% (Data available from 1/1/2016 forward) MIRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MIRA shares? During the previous two years, the following institutional investors and hedge funds held shares of MIRA Pharmaceuticals shares: Cross Staff Investments Inc ($476K), Suncoast Equity Management ($117K), and Virtu Financial LLC ($69K), Praetorian Wealth Management Inc. ($30K).Learn more on MIRA's institutional investors. What percentage of MIRA Pharmaceuticals stock is owned by institutional investors? 35.16% of MIRA Pharmaceuticals stock is owned by institutional investors. Learn more on MIRA's institutional investor holdings. Which institutional investors have been buying MIRA Pharmaceuticals stock? The following institutional investors have purchased MIRA Pharmaceuticals stock in the last 24 months: Cross Staff Investments Inc ($383.40K), Suncoast Equity Management ($90K), Virtu Financial LLC ($48.40K), and Praetorian Wealth Management Inc. ($27.50K). How much institutional buying is happening at MIRA Pharmaceuticals? Institutional investors have bought a total of 549,298 shares in the last 24 months. This purchase volume represents approximately $614.23K in transactions. Which MIRA Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold MIRA Pharmaceuticals stock in the last 24 months: Cross Staff Investments Inc ($17.50K). How much institutional selling is happening at MIRA Pharmaceuticals? Institutional investors have sold a total of 17,500 shares in the last 24 months. This volume of shares sold represents approximately $22.75K in transactions. Related Companies Aerovate Therapeutics Institutional Ownership ESSA Pharma Institutional Ownership Unicycive Therapeutics Institutional Ownership PDS Biotechnology Institutional Ownership Theratechnologies Institutional Ownership Annovis Bio Institutional Ownership OptiNose Institutional Ownership Repare Therapeutics Institutional Ownership Vistagen Therapeutics Institutional Ownership Vor Biopharma Institutional Ownership This page (NASDAQ:MIRA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
